A homegrown model for heart patients worldwide

EDBI Pte Ltd has been actively partnering companies transforming healthcare through digitalisation, such as with homegrown Biofourmis, which has now received the FDA’s first-ever Breakthrough Device designation for a heart failure digital therapeutic. This will bring the company significantly closer to delivering a new model of care to patients worldwide living with heart failure.

Notice: Unauthorised use of the EDBI name and branding in Japan. EDBI officers will never solicit from the public or offer incentives for participation in our programmes. Report any incident to [email protected] if you are unsure if something is a scam.
This is default text for notification bar